NUK - logo
E-viri
Recenzirano Odprti dostop
  • Idiopathic thrombocytopenic...
    Idiopathic thrombocytopenic purpura induced by nivolumab in a metastatic melanoma patient with elevated PD-1 expression on B cells
    Kanameishi, S.; Otsuka, A.; Nonomura, Y.; Fujisawa, A.; Endo, Y.; Kabashima, K.

    Annals of oncology, March 2016, 2016-Mar, 2016-03-00, Letnik: 27, Številka: 3
    Journal Article

    Nivolumab has shown promising early results in patients with advanced malignancies, including melanoma and lung cancer, with generally manageable side effects. On the other hand, recent studies showed that the immune activation caused by PD-1 blockade might promote severe autoimmune toxicity. Herein, we report a case of idiopathic thrombocytopenic purpura during nivolumab therapy.

Vnos na polico